Amgen Inc.

NasdaqGS:AMGN 株式レポート

時価総額:US$158.3b

Amgen バランスシートの健全性

財務の健全性 基準チェック /16

Amgenの総株主資本は$7.5B 、総負債は$60.4Bで、負債比率は802.4%となります。総資産と総負債はそれぞれ$90.9Bと$83.4Bです。 Amgenの EBIT は$6.7Bで、利息カバレッジ比率2.1です。現金および短期投資は$9.0Bです。

主要情報

802.4%

負債資本比率

US$60.40b

負債

インタレスト・カバレッジ・レシオ2.1x
現金US$9.01b
エクイティUS$7.53b
負債合計US$83.36b
総資産US$90.88b

財務の健全性に関する最新情報

Recent updates

Amgen Sells Off: Keep Calm And Buy The Dip

Nov 18

Amgen's (NASDAQ:AMGN) Problems Go Beyond Weak Profit

Nov 08
Amgen's (NASDAQ:AMGN) Problems Go Beyond Weak Profit

Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market

Nov 03

Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Nov 02
Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List

Oct 25

Amgen: Pipeline Updates, Uplizna Performs And Rocatinlimab Underwhelms

Sep 26

Amgen: Growth Is Still A Better Choice

Aug 28

Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next

Aug 09
Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next

Amgen: Shows Why Dividend Investing Is Getting Tougher

Aug 07

Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt

Jul 26
Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Amgen Inc. (NASDAQ:AMGN)

Jul 11
The Price Is Right For Amgen Inc. (NASDAQ:AMGN)

Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum

Jul 05

Amgen: You Haven't Seen Anything Yet

Jun 17

Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card

Jun 04

Amgen Stock: Poised To Break Out (Technical Analysis)

May 21

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?

May 04
Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?

Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet

May 01

Amgen: The Giant With An Impressive Pipeline

Apr 15

Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Apr 01
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock

Mar 31

Amgen Will Benefit From Increased Medical Spending

Mar 12

Amgen: A Good Dividend Growth Stock For The Watch List

Mar 04

Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Feb 21
Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Feb 16
Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable

Feb 08

Amgen: Accelerating The Business And Dividend Growth

Jan 29

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Jan 29
Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks

Jan 22

Is Amgen (NASDAQ:AMGN) A Risky Investment?

Dec 28
Is Amgen (NASDAQ:AMGN) A Risky Investment?

Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

Dec 13
Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

財務状況分析

短期負債: AMGNの 短期資産 ( $26.8B ) が 短期負債 ( $20.3B ) を超えています。

長期負債: AMGNの短期資産 ( $26.8B ) は 長期負債 ( $63.0B ) をカバーしていません。


デット・ツー・エクイティの歴史と分析

負債レベル: AMGNの 純負債対資本比率 ( 682.7% ) は 高い と見なされます。

負債の削減: AMGNの負債対資本比率は、過去 5 年間で272.6%から802.4%に増加しました。

債務返済能力: AMGNの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 12% )。

インタレストカバレッジ: AMGNの負債に対する 利息支払いEBIT ( 2.1 x coverage) によって 十分にカバーされていません


貸借対照表


健全な企業の発掘